NFKB1 and ovarian cancer: As an anti‐tumour molecule, miR‐508‐3p is down‐regulated in gastric cancer (GC) and suppressed GC cell proliferation and invasion by targeting NF‐κB pathway; miR‐508‐3p expression also is reduced in ovarian cancer and targets MAPK signalling pathways.